Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06333834
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-03-05
Brief Title:
Assessment of the Efficacy of Scorpion Antivenom Therapy in a Dose-response Manner in Patients With Scorpionism
Sponsor:
Selene Guadalupe Huerta Olvera
Organization:
University of Guadalajara
Study Overview
Official Title:
Assessment of the Efficacy of Anti-scorpion Venom Therapy in a Dose-response Manner Following the Principles of Rational Drug Use in Patients With Scorpionism a Non-inferiority Randomized Double-blind Controlled Clinical Trial
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The clinical study aims to compare the effectiveness of applying two different regimens of scorpion antivenom therapy In the first regimen control the medication is administered to all patients and depending on the severity of the condition the dosage varies In the experimental regimen an identical dose of scorpion antivenom is administered to patients exhibiting signs and symptoms of scorpion sting intoxication in addition to pain and other symptoms at the sting site The primary response variable is the time taken for signs and symptoms to resolve but differences in complications adverse effects venom and antivenom concentration in the blood and the need for other therapeutic measures are also evaluated
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None